发明名称 5c8 antigen
摘要 This invention provides for an isolated protein specifically recognized by monoclonal antibody 5c8 produced by the hybridoma having ATCC Accession No. HB 10916. This invention also provides for an isolated protein having substantially the same biological activity as the aforementioned isolated protein. In addition, this invention provides for a pharmaceutical composition comprising the isolated protein and a pharmaceutically acceptable carrier.
申请公布号 US6455044(B1) 申请公布日期 2002.09.24
申请号 US19990291667 申请日期 1999.04.14
申请人 THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK 发明人 LEDERMAN SETH;CHESS LEONARD;YELLIN MICHAEL J.
分类号 G01N33/50;A61K35/76;A61K38/00;A61K38/17;A61K39/00;A61K39/395;A61K47/48;A61K48/00;A61K49/00;A61K51/10;A61P3/10;A61P5/14;A61P7/04;A61P7/06;A61P17/06;A61P19/02;A61P21/04;A61P29/00;A61P31/14;A61P35/00;A61P35/02;A61P37/00;A61P37/02;A61P37/06;A61P37/08;A61P43/00;C07K14/47;C07K14/705;C07K14/725;C07K16/28;C12N1/15;C12N1/19;C12N1/21;C12N5/09;C12N5/10;C12N15/02;C12N15/09;C12N15/12;C12N15/13;C12P21/02;C12P21/08;C12Q1/02;C12R1/91;G01N33/15;G01N33/53;G01N33/566;G01N33/574;G01N33/577;(IPC1-7):A61K38/17 主分类号 G01N33/50
代理机构 代理人
主权项
地址